drugset / Trial / NCT02703259

Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management

NCT02703259

Phase 4 Completed 137 enrolled Christiana Care Health Services
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of the investigators' study is to assess the efficacy of a single dose of preoperative gabapentin within an enhanced recovery after surgery protocol in acute postoperative pain reduction for women undergoing a minimally invasive hysterectomy. Participants who consent to participate will be randomized to either a control group without gabapentin or to a study arm and receive gabapentin 600 mg prior to their planned surgery. The investigators will collect data on postoperative narcotic use, subjective pain as rated by a numeric pain scale, in addition to any adverse effects of single dose gabapentin use.

Timeline

Start
2016-06
Primary completion
2017-07
Completion
2017-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg Oral
Comparator Acetaminophen Small molecule 975 mg Oral
Comparator Celecoxib Other / unclassified 400 mg Oral

Indications

No indication recorded.